ShareValue scores for 688089.SHG: Valuation 61, Quality 56, Growth 29, Health 31.

688089.SHG
SSE

Cabio Biotech Wuhan Co Ltd

CN¥7.73(-0.64%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
56
Moderate
Business Strength
Growth
29
Weak
Revenue & Earnings
Health
31
Stressed
Financial Stability
Momentum
35
Bearish
Price Trend

Company Details

About

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026